CJC-1295 with DAC and GHRP-6 Interaction

Monitor
Researched 90% confidence

CJC-1295 with DAC and GHRP-6 have an interaction requiring monitoring for interaction with 90% confidence. GHRP pulse effects diminished with continuous GH elevation. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

GHRP-6

Growth Hormone Releasing Peptide-6 | Hexapeptide GHS

GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R1a), the same receptor activated by ghrelin. This initiates a signaling cascade in the hypothalamus and pituitary gland, triggering a rapid pulse of natural GH secretion.

Half-life: 15-60 minutes Typical dose: 100-300 mcg per injection growth hormone, weight loss
ghrelin receptorigf1 carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 with DAC, GHRP-6). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, GHRP-6). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 with DAC with GHRP-6?

Yes, but with caution. GHRP pulse effects diminished with continuous GH elevation. Regular monitoring is advised.

Is CJC-1295 with DAC and GHRP-6 safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and GHRP-6?

GHRP pulse effects diminished with continuous GH elevation. This assessment has 90% confidence and is based on documented research data.

How should I time CJC-1295 with DAC and GHRP-6?

CJC-1295 with DAC has a half-life of 6-8 days and GHRP-6 has a half-life of 15-60 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs GHRP-6

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.